Relay Therapeutics, Inc. RLAY Common Stock
Common Stock at other companies
Other financials
Where this comes from
Reported directly by Relay Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CommonStockValue.
The official record: Relay Therapeutics, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Relay Therapeutics, Inc.'s common stock.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Relay Therapeutics, Inc.'s common stock?
- Relay Therapeutics, Inc. (RLAY) reported common stock of $182K in Q1 2026.
- How has Relay Therapeutics, Inc.'s common stock changed year-over-year?
- Relay Therapeutics, Inc.'s common stock increased by 8.3% year-over-year, from $168K to $182K.
- What is the long-term trend for Relay Therapeutics, Inc.'s common stock?
- Over 5 years (2020 to 2025), Relay Therapeutics, Inc.'s common stock has grown at a 13.3% compound annual growth rate (CAGR), from $90K to $168K.
- What does common stock mean?
- The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).